NCT03821272 2025-10-08
A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients
University of Arkansas
Phase 1/2 Completed
University of Arkansas
Aalborg University Hospital
Ciusss de L'Est de l'Île de Montréal
Xiangya Hospital of Central South University
Yonsei University
University of Oklahoma